US Patent Issued to GUANGDONG TAIHE MEDICINE SCIENCE & TECHNOLOGY on Feb. 24 for "Anti-tumor fusion protein, preparation method therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,403, issued on Feb. 24, was assigned to GUANGDONG TAIHE MEDICINE SCIENCE & TECHNOLOGY Co. LTD (Guangdong, China).

"Anti-tumor fusion protein, preparation method therefor and application thereof" was invented by Yingqi Zhang (Shaanxi, China) and Fulin Fan (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are an anti-tumor fusion protein, a preparation method therefor and an application thereof. Specifically, the fusion protein contacts a CPP element, an optional linking element, and a SH2 domain of SHP2 or SHP1 or an active fragment thereof. The obtained fusion protein has an extremely excellent anti-tumor effect."

The patent...